PRIDINOL HYDROCHLORIDE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C20H25NO.ClH
Molecular Weight	331.88
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

Cl.OC(CCN1CCCCC1)(C2=CC=CC=C2)C3=CC=CC=C3

InChI

InChIKey=IECCHUISCGCKKS-UHFFFAOYSA-N

InChI=1S/C20H25NO.ClH/c22-20(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21;/h1-2,4-7,10-13,22H,3,8-9,14-17H2;1H

HIDE SMILES / InChI

Molecular Formula	ClH
Molecular Weight	36.461
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C20H25NO
Molecular Weight	295.4186
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: http://www.mims.com/india/drug/info/pridinol?type=full&mtype=generic | https://www.ncbi.nlm.nih.gov/pubmed/12935797 | http://mmpharm1.tradekorea.com/product/detail/P260632/Skeletal-Muscle-Relaxants.html?minisiteprodgroupno=29432

Pridinol mesilate is a centrally acting muscle relaxant that is used in the symptomatic treatment of muscle spasm. It is also used as the hydrochloride salt for its antimuscarinic activity in the management of parkinsonism.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Muscarinic acetylcholine receptor 160 Target ID: CHEMBL2094109 Sources: http://www.genome.jp/dbget-bin/www_bget?D08418 \| https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+2684 \| https://www.ncbi.nlm.nih.gov/pubmed/8102927	Antagonist 2778

Conditions

Condition	Modality	Targets	Highest Phase	Product
Muscle spasm 40 Sources: http://mmpharm1.tradekorea.com/product/detail/P260632/Skeletal-Muscle-Relaxants.html?minisiteprodgroupno=29432 https://www.ncbi.nlm.nih.gov/pubmed/12935797	Primary		Approved 8429	Pridinol Approved Use Muscle spasms

PubMed

Title	Date	PubMed
Drug-human serum albumin binding studied by capillary electrophoresis with electrochemiluminescence detection.	2004 Oct	15490448
Suicide by multidrug ingestion: hypothesis on the role played by the self-administration of activated charcoal.	2007 Mar	17325466
Validated stability-indicating HPLC method for the determination of pridinol mesylate. Kinetics study of its degradation in acid medium.	2008 Dec 1	18922659
Development and validation of an HPLC method for the determination of process-related impurities in pridinol mesylate, employing experimental designs.	2009 Nov 10	19854345
Development and validation of a dissolution test for meloxicam and pridinol mesylate from combined tablet formulation.	2010 Mar	20838523
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.	2011 Jul 14	21599003

Patents

Sample Use Guides

In Vivo Use Guide

Oral Muscle spasms Adult: As mesilate: Usual initial: 2-8 mg tid; Maintenance: 4-8 mg daily.

Route of Administration: Oral

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Fri Dec 15 18:44:23 UTC 2023` Edited by `admin` on `Fri Dec 15 18:44:23 UTC 2023`
Record UNII	3HI2Q2Y868
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PRIDINOL HYDROCHLORIDE

Common Name

English

1,1-DIPHENYL-3-(PIPERIDIN-1-YL)PROPAN-1-OL HYDROCHLORIDE

Systematic Name

English

PRIDINOL HYDROCHLORIDE [MI]

Common Name

English

PRIDINOL HCL

Common Name

English

Pridinol hydrochloride [WHO-DD]

Common Name

English

Code System Code Type Description

RXCUI

236869